{"id":50072,"date":"2022-10-26T07:01:55","date_gmt":"2022-10-26T05:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/"},"modified":"2022-10-26T07:01:55","modified_gmt":"2022-10-26T05:01:55","slug":"dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/","title":{"rendered":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Sanofi will use the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at its new-generation \u201cEVolutive Facilities\u201d (EVF) in France and Singapore<\/b>\n<\/li>\n<li>\n<b>3DEXPERIENCE platform models will enable Sanofi to generate virtual twins to drive the agility, reliability and performance of Sanofi\u2019s new facilities<\/b>\n<\/li>\n<li>\n<b>Improved agility and flexibility will enable faster implementation of changes, advancing Sanofi\u2019s ambition to secure its product pipeline<\/b>\n<\/li>\n<\/ul>\n<p>VELIZY-VILLACOUBLAY, France&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/3DEXPERIENCE?src=hash\" target=\"_blank\" rel=\"noopener\">#3DEXPERIENCE<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.3ds.com&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Dassault+Syst%26egrave%3Bmes&amp;index=1&amp;md5=a8d5bf0f78b972480ed461af380ea102\" rel=\"nofollow noopener\" shape=\"rect\">Dassault Syst\u00e8mes<\/a> (Euronext Paris: FR0014003TT8, DSY.PA) and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sanofi.com%2Fen&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Sanofi&amp;index=2&amp;md5=3bd51d576240dedbd7c1e9749afb0e2b\" rel=\"nofollow noopener\" shape=\"rect\">Sanofi<\/a> today announced their partnership to optimize \u201cEVolutive Facility\u201d production at Sanofi\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sanofi.com%2Fen%2Fmedia-room%2Fpress-releases%2F2020%2F2020-06-16-12-00-00&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=future+state-of-the-art+modular+manufacturing+facilities&amp;index=3&amp;md5=f12471eb7504162140f4d81caf079f9c\" rel=\"nofollow noopener\" shape=\"rect\">future state-of-the-art modular manufacturing facilities<\/a> in France and Singapore. The partnership, which expands their long-standing collaboration in life sciences and healthcare, will leverage virtual twin experiences to enable agile and flexible operations that advance Sanofi\u2019s ambition to secure its product portfolio.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/5\/3DS_Corp_Logotype_Blue_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg\"><\/a><\/p>\n<p>\nSanofi will use Dassault Syst\u00e8mes\u2019 \u201c<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmy.3dexperience.3ds.com%2Fwelcome%2Fcompass-world%2F3dexperience-life-sciences-and-healthcare%2Fmade-to-cure-for-biopharma&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Made+to+Cure+for+BioPharma&amp;index=4&amp;md5=8275c6dd0cb6afe6daa314b67b0aa33d\" rel=\"nofollow noopener\" shape=\"rect\">Made to Cure for BioPharma<\/a>\u201d industry solution experience based on the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at the two \u201cEVolutive Facilities.\u201d These will rely on single-use technology and mobile equipment to manufacture up to four products simultaneously and sustainably by selecting the most advanced technologies to reduce their energy consumption. The platform provides a virtual environment for collaborative innovation and end-to-end data management across the life cycle. Sanofi can experience the manufacturing systems under development and their operation virtually and optimize scale up and industrialization processes before deploying them.\n<\/p>\n<p>\n\u201cWe want to improve people\u2019s lives by giving them faster access to vaccines and treatments while minimizing the environmental impacts of our activities,\u201d said Ana Alves, EVolutive Facility Global Project Head &amp; Site Head of Neuville sur Saone, Sanofi. \u201cDassault Syst\u00e8mes delivers the technology we need to accelerate the introduction of new products in the facility by supporting the collaborative works of our teams and by strengthening the standardization of designs and models. It will also bring capabilities to reach our objective to produce several products in the EVF in an optimized schedule, thanks to the digital twin. Then, the 3DEXPERIENCE platform will help us to address the complexity of the product lifecycle management in a highly regulated environment and for the benefit of our patients.\u201d\n<\/p>\n<p>\nPharmaceutical manufacturers must qualify facilities, equipment and processes before production to ensure safety and quality. This can take weeks or months depending on the equipment configurations and process parameters for different product recipes. Virtual twins enable manufacturers to standardize modules, reduce this timeframe, and boost their ability to quickly and massively produce crucial therapies.\n<\/p>\n<p>\nWith a virtual twin, Sanofi can visualize and simulate the recipe, equipment and consumables that a particular process requires, as well as the flow and activity of the modules and operators in the \u201cballroom\u201d \u2013 a flexible and adaptable area that enables manufacturers to quickly switch between processes. Sanofi can add, remove and replace functional elements and process steps as needed in a seamless way, and reconfigure the production lines for a fast changeover from one product to another one. It can also accelerate the main activities of the life cycle of new modules, processes and facilities more quickly and catalog them into its product life cycle management for reuse and faster product changeover.\n<\/p>\n<p>\n\u201cThe pandemic made it clear: BioPharmas must be able to maximize efficiency and quickly provide high-quality, innovative therapeutics to patients worldwide,\u201d said Claire Biot, Vice President, Life Sciences &amp; Healthcare Industry, Dassault Syst\u00e8mes. \u201cSanofi is responding to this challenge with next generation modular manufacturing that can transform the speed at which products reach patients. Thanks to the 3DEXPERIENCE platform, Sanofi will implement new products right the first time, with faster production ramp-ups and concurrent process production for built-in flexibility. Ergonomics on the shop floor can be simulated and improved.\u201d\n<\/p>\n<p>\n<b>FOR MORE INFORMATION<\/b>\n<\/p>\n<p>\nSanofi\u2019s \u201cEVolutive Facilities\u201d in France and Singapore: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sanofi.com%2Fen%2Fyour-health%2Fvaccines%2Fproduction&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.sanofi.com%2Fen%2Fyour-health%2Fvaccines%2Fproduction&amp;index=5&amp;md5=dcb464565078ef8543ffa5ce23e664cc\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.sanofi.com\/en\/your-health\/vaccines\/production<\/a>\n<\/p>\n<p>\nDassault Syst\u00e8mes\u2019 industry solution experiences for the Life Science &amp; Healthcare Industry: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fifwe.3ds.com%2Flife-sciences-and-healthcare-solutions&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=https%3A%2F%2Fifwe.3ds.com%2Flife-sciences-and-healthcare-solutions&amp;index=6&amp;md5=88af762a231d5d8886d3ca36e6ac0268\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ifwe.3ds.com\/life-sciences-and-healthcare-solutions<\/a>\n<\/p>\n<p>\nDassault Syst\u00e8mes\u2019 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.3ds.com&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.3ds.com&amp;index=7&amp;md5=11c9d95695713266c07d530aecc609db\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/www.3ds.com<\/a>\n<\/p>\n<p>\n<b>SHARE THIS ON TWITTER<\/b>\n<\/p>\n<p>\nNew partnership between @sanofi @Dassault3DS aims to optimize production at Sanofi\u2019s future facilities in France and Singapore #3DEXPERIENCE\n<\/p>\n<p class=\"bwalignc\">\nConnect with Dassault Syst\u00e8mes on<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FDassault3DS&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Twitter&amp;index=8&amp;md5=9d4381b0641149ab665a69dda6546131\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>| <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FDassaultSystemes&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Facebook&amp;index=9&amp;md5=aa733fe148445d0c2df1b8f42331d924\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>| <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fdassaultsystemes&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=10&amp;md5=9fe8fa04955da5f64f20d33738c7d925\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>| <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2FDassaultSystemes&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=Youtube&amp;index=11&amp;md5=8dec179e7ab2118bca42df14ec3489c9\" rel=\"nofollow noopener\" shape=\"rect\">Youtube<\/a>\n<\/p>\n<p>\n<b>ABOUT DASSAULT SYST\u00c8MES<\/b>\n<\/p>\n<p>\nDassault Syst\u00e8mes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers. Dassault Syst\u00e8mes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.3ds.com%2F&amp;esheet=52952723&amp;newsitemid=20221025006103&amp;lan=en-US&amp;anchor=www.3ds.com&amp;index=12&amp;md5=f251fa61069cc2349df124ab2be1a274\" rel=\"nofollow noopener\" shape=\"rect\">www.3ds.com<\/a>\n<\/p>\n<p>\n<b>ABOUT SANOFI<\/b>\n<\/p>\n<p>\nWe are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people\u2019s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.\n<\/p>\n<p>\nSanofi is listed on EURONEXT: SAN and NASDAQ: SNY.\n<\/p>\n<p>\n\u00a9 Dassault Syst\u00e8mes. All rights reserved. 3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Syst\u00e8mes, a French \u201csoci\u00e9t\u00e9 europ\u00e9enne\u201d (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and\/or other countries.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Dassault Syst\u00e8mes Press Contacts<\/b><br \/>Corporate \/ France<br \/>\n<br \/>Arnaud MALHERBE<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;a&#x72;&#110;a&#x75;&#100;&#x2e;&#x6d;a&#x6c;&#104;e&#x72;&#98;e&#x40;&#51;&#x64;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;r&#x6e;&#97;u&#x64;&#46;&#x6d;&#x61;l&#x68;&#101;r&#x62;&#101;&#x40;&#51;d&#x73;&#46;c&#x6f;&#109;<\/a><br \/>+33 (0)1 61 62 87 73\n<\/p>\n<p>\nNorth America<br \/>\n<br \/>Natasha LEVANTI<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;n&#x61;&#116;a&#x73;&#104;&#x61;&#x2e;l&#x65;&#118;a&#x6e;&#116;i&#x40;&#51;&#x64;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">nat&#97;&#115;&#104;&#97;&#x2e;&#x6c;&#x65;&#x76;&#x61;&#x6e;&#x74;i&#64;3&#100;&#115;&#46;&#99;&#111;&#x6d;<\/a><br \/>+1 (508) 449 8097\n<\/p>\n<p>\nEMEAR<br \/>\n<br \/>Virginie BLINDENBERG<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#118;&#x69;&#x72;&#103;&#x69;&#x6e;i&#101;&#x2e;b&#108;&#x69;&#x6e;&#100;&#x65;&#x6e;b&#101;&#x72;g&#64;&#x33;&#x64;&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#118;&#105;&#x72;g&#105;&#x6e;&#x69;e&#46;&#x62;&#x6c;i&#110;&#x64;&#x65;n&#98;&#x65;&#x72;g&#64;&#x33;&#x64;s&#46;&#x63;o&#109;<\/a><br \/>+33 (0) 1 61 62 84 21\n<\/p>\n<p>\nChina<br \/>\n<br \/>Grace MU<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;g&#114;&#x61;c&#101;&#x2e;&#x6d;u&#64;&#x33;d&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#103;r&#x61;c&#x65;&#46;&#x6d;u&#x40;&#51;&#x64;&#115;&#x2e;&#99;&#x6f;&#109;<\/a><br \/>+86 10 6536 2288\n<\/p>\n<p>\nIndia<br \/>\n<br \/>Kriti ASHOK<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:kr&#x69;&#x74;&#x69;&#x2e;&#97;&#115;hok&#x40;&#x33;&#x64;&#x73;&#46;&#99;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#x72;&#105;&#116;&#105;&#46;&#x61;&#x73;&#x68;&#111;&#107;&#64;3&#x64;&#x73;&#x2e;&#99;&#111;m<\/a><br \/>+91 9741310607\n<\/p>\n<p>\nJapan<br \/>\n<br \/>Yukiko SATO<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:yu&#x6b;&#x69;&#x6b;&#x6f;&#46;&#115;ato&#x40;&#x33;&#x64;&#x73;&#46;&#99;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x79;&#117;&#107;i&#x6b;&#x6f;&#46;s&#x61;&#x74;&#111;&#64;3&#x64;&#115;&#46;c&#x6f;&#x6d;<\/a><br \/>+81 3 4321 3841\n<\/p>\n<p>\nKorea<br \/>\n<br \/>Jeemin JEONG<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x6a;&#x65;&#x65;m&#105;&#x6e;&#x2e;&#x6a;e&#111;&#x6e;&#x67;&#x40;3&#100;&#x73;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#101;e&#x6d;&#105;n&#x2e;&#106;e&#x6f;&#110;g&#x40;&#51;d&#x73;&#46;c&#x6f;&#109;<\/a><br \/>+82 2 3271 6653\n<\/p>\n<p>\nAP South<br \/>\n<br \/>Jessica TAN<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:jessi&#99;&#97;&#46;&#116;&#97;&#110;&#64;&#51;&#100;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#x65;&#x73;s&#105;&#x63;a&#46;&#x74;&#x61;&#110;&#x40;&#x33;d&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>+65 6511 6248\n<\/p>\n<p>\nSanofi Press Contacts<br \/>\n<br \/>Sandrine Guendoul | + 33 6 25 09 14 25 | <a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;&#111;&#x3a;&#x73;&#97;n&#x64;&#114;i&#x6e;&#x65;&#46;g&#x75;&#101;n&#x64;&#x6f;&#117;l&#x40;&#115;a&#x6e;&#x6f;&#102;i&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x73;&#x61;&#110;d&#x72;&#x69;&#x6e;&#101;&#46;&#x67;&#x75;&#x65;&#110;d&#x6f;&#x75;&#x6c;&#64;s&#x61;&#x6e;&#x6f;&#102;i&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>Nicolas Obrist | + 33 6 77 21 27 55 | <a target=\"_blank\" href=\"&#x6d;&#97;&#105;&#x6c;&#x74;&#111;&#58;&#x6e;&#x69;&#99;&#111;&#x6c;&#x61;&#115;&#46;&#x6f;&#x62;&#114;&#105;&#x73;&#x74;&#64;&#115;&#x61;&#x6e;&#111;&#102;&#x69;&#x2e;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6e;&#x69;&#x63;&#x6f;&#108;&#97;s&#46;o&#x62;&#x72;&#x69;&#x73;&#116;&#64;san&#x6f;&#x66;&#x69;&#x2e;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi will use the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at its new-generation \u201cEVolutive Facilities\u201d (EVF) in France and Singapore 3DEXPERIENCE platform models will enable Sanofi to generate virtual twins to drive the agility, reliability and performance of Sanofi\u2019s new facilities Improved agility and flexibility will enable faster implementation of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50072","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Sanofi will use the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at its new-generation \u201cEVolutive Facilities\u201d (EVF) in France and Singapore 3DEXPERIENCE platform models will enable Sanofi to generate virtual twins to drive the agility, reliability and performance of Sanofi\u2019s new facilities Improved agility and flexibility will enable faster implementation of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T05:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d\",\"datePublished\":\"2022-10-26T05:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/\"},\"wordCount\":1045,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006103\\\/en\\\/734381\\\/21\\\/3DS_Corp_Logotype_Blue_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/\",\"name\":\"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006103\\\/en\\\/734381\\\/21\\\/3DS_Corp_Logotype_Blue_RGB.jpg\",\"datePublished\":\"2022-10-26T05:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006103\\\/en\\\/734381\\\/21\\\/3DS_Corp_Logotype_Blue_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006103\\\/en\\\/734381\\\/21\\\/3DS_Corp_Logotype_Blue_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/","og_locale":"en_US","og_type":"article","og_title":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend","og_description":"Sanofi will use the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at its new-generation \u201cEVolutive Facilities\u201d (EVF) in France and Singapore 3DEXPERIENCE platform models will enable Sanofi to generate virtual twins to drive the agility, reliability and performance of Sanofi\u2019s new facilities Improved agility and flexibility will enable faster implementation of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-26T05:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d","datePublished":"2022-10-26T05:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/"},"wordCount":1045,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/","url":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/","name":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg","datePublished":"2022-10-26T05:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221025006103\/en\/734381\/21\/3DS_Corp_Logotype_Blue_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dassault-systemes-partners-with-sanofi-to-optimize-tech-transfer-and-industrialization-at-its-future-evolutive-facilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dassault Syst\u00e8mes Partners with Sanofi to Optimize Tech Transfer and Industrialization at Its Future \u201cEVolutive Facilities\u201d"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50072"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50072\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}